(Q40419007)

20 September 2017

1 reference

title

Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan). (English)

1 reference

20 September 2017

Olsen JO

1

1 reference

20 September 2017

Pozderac RV

2

1 reference

20 September 2017

Hinkle G

3

1 reference

20 September 2017

Hill T

4

1 reference

20 September 2017

O'Dorisio TM

5

1 reference

20 September 2017

Schirmer WJ

6

1 reference

20 September 2017

Ellison EC

7

1 reference

20 September 2017

O'Dorisio MS

8

1 reference

20 September 2017

1 July 1995

1 reference

Seminars in Nuclear Medicine

20 September 2017

1 reference

20 September 2017

25

1 reference

20 September 2017

3

1 reference

20 September 2017

251-261

1 reference

Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging, and treatment of tumors

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

Mechanisms of action of long-acting analogs of somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

In vitro detection of somatostatin receptors in human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

Clinical applications of somatostatin analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980014-X

10.1016/S0001-2998(95)80014-X

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference